Balyasny Asset Management »

Crinetics Pharmaceuticals In shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $585k 14k 41.65
2024-09-30 $2.7M 53k 51.10
2024-06-30 $5.1M 115k 44.79
2023-06-30 $524k 29k 18.02
2022-12-31 $14k 744 18.30

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Driehaus Capital Management
Farallon Capital Management
EcoR1 Capital
Henderson Group
Paradigm Biocapital Advisors
Geode Capital Management
State Street Corporation
Jennison Associates
Point72 Asset Management
Siren
Novo A/S

View all funds holding Crinetics Pharmaceuticals In